Jett Foundation

Jett Foundation empowers people and families impacted by Duchenne muscular dystrophy through the development of transformative programming, educational opportunities, and ongoing support for every stage of a Duchenne journey.


Everyday, we strive to provide our community with helpful resources, interactive programs, and tools to use on a Duchenne journey.


Thanks to the unwavering support of community members like you, Jett Foundation has been able to continue serving our Duchenne muscular dystrophy community in creative and safe for many years.


Make a difference in the lives of those living with Duchenne and become one of the many who selflessly give their time and talent to support our mission.

Become a Partner

Our team at Jett Foundation will work with you and your company to customize a partnership. Let us explore with you how, together, we can serve a community full of unmet needs.

Featured Programs

Jett Giving Fund

Jett Giving Fund was established in 2017 to assist families impacted by Duchenne muscular dystrophy in purchasing unaffordable, but vital medical and accessibility equipment.

Camp Promise

Camp Promise is a free, week-long camp and year-round program for kids, teens, and adults with neuromuscular disorders.

Family Workshops

Family Workshops are our national educational program that brings together clinicians, researchers, and families affected by Duchenne to learn about care, crucial information, and resources in many cities each year.

Support Groups

Our support program focuses on building stronger support systems for families affected by Duchenne in their local community through story-telling, education, and grief-management.

Upcoming Events

Porch Nite: Managing All Aspects of Siblings

Monday, September 26, 2022

7:00PM – 9:00PM ET

Join us for Porch Nite to discuss managing all aspects of siblings with fellow moms in the Duchenne space!

Duchenne News

September 30, 2022
Solid Biosciences enters a definitive merger to acquire AavantiBio.
September 29, 2022
Sarepta Therapeutics Submits Biologics License Application for SRP-9001 for the Treatment of Ambulant Patients with Duchenne Muscular Dystrophy.
September 28, 2022
PepGen announces the completed results from its Phase 1 healthy normal volunteer (HNV) trial of PGN-EDO51 for Duchenne.

Recent Blog Posts

September 30, 2022
Jett Foundation assists Tennessee family with rent support.
September 30, 2022
Jett Foundation extends assistance to families in the wake of Hurricane Ian.
September 29, 2022
Jett Foundation’s Go! for Duchenne team attends 2022 Rodman Ride for Kids.

Donate Today

Help us fulfill our mission by donating to help us partner with individuals and families through empowering educational programming, transformational direct service experiences, and by accelerating development of life-changing treatments.